{"id":"https://openalex.org/W4404038356","doi":"https://doi.org/10.1038/s41573-024-01059-3","title":"The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap","display_name":"The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap","publication_year":2024,"publication_date":"2024-11-04","ids":{"openalex":"https://openalex.org/W4404038356","doi":"https://doi.org/10.1038/s41573-024-01059-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/39496921"},"language":"en","primary_location":{"id":"doi:10.1038/s41573-024-01059-3","doi":"https://doi.org/10.1038/s41573-024-01059-3","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41573-024-01059-3","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.utwente.nl/en/publications/2a674d39-c112-4535-b77c-1e5ce38a2363","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059884371","display_name":"Anneliene Hechtelt Jonker","orcid":"https://orcid.org/0000-0001-5883-7610","observed_orcids":["https://orcid.org/0000-0001-5883-7610"]},"institutions":[{"id":"https://openalex.org/I94624287","display_name":"University of Twente","ror":"https://ror.org/006hf6230","country_code":"NL","type":"education","lineage":["https://openalex.org/I94624287"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anneliene H. Jonker","raw_affiliation_strings":["HTSR, TechMed Centre, University of Twente, Enschede, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-5883-7610","affiliations":[{"raw_affiliation_string":"HTSR, TechMed Centre, University of Twente, Enschede, The Netherlands","institution_ids":["https://openalex.org/I94624287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106681774","display_name":"Elena-Alexandra T\u00e3taru","orcid":"https://orcid.org/0009-0007-7339-7175","observed_orcids":["https://orcid.org/0009-0007-7339-7175"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elena-Alexandra Tataru","raw_affiliation_strings":["French National Institute of Health and Medical Research (INSERM), Paris, France","International Rare Diseases Research Consortium (IRDiRC), Paris, France"],"raw_orcid":"https://orcid.org/0009-0007-7339-7175","affiliations":[{"raw_affiliation_string":"French National Institute of Health and Medical Research (INSERM), Paris, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"International Rare Diseases Research Consortium (IRDiRC), Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079780434","display_name":"Holm Grae\u00dfner","orcid":"https://orcid.org/0000-0001-9803-7183","observed_orcids":["https://orcid.org/0000-0001-9803-7183"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Holm Graessner","raw_affiliation_strings":["Centre for Rare Diseases, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Rare Diseases, University Hospital T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015936523","display_name":"David Dimmock","orcid":"https://orcid.org/0000-0001-6690-2523","observed_orcids":["https://orcid.org/0000-0001-6690-2523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Dimmock","raw_affiliation_strings":["Creyon Bio, San Diego, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-6690-2523","affiliations":[{"raw_affiliation_string":"Creyon Bio, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055346025","display_name":"Adam Jaff\u00e9","orcid":"https://orcid.org/0000-0002-1963-5415","observed_orcids":["https://orcid.org/0000-0002-1963-5415","https://orcid.org/0000-0003-1337-1751"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adam Jaffe","raw_affiliation_strings":["School of Clinical Medicine, University of New South Wales, Faculty of Medicine, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Faculty of Medicine, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089939981","display_name":"Gareth S Baynam","orcid":"https://orcid.org/0000-0003-4920-9553","observed_orcids":["https://orcid.org/0000-0003-4920-9553"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2800419323","display_name":"Princess Margaret Hospital for Children","ror":"https://ror.org/04ec98z42","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800419323","https://openalex.org/I2800882159","https://openalex.org/I4387155440"]},{"id":"https://openalex.org/I4387155440","display_name":"Perth Children's Hospital","ror":"https://ror.org/015zx6n37","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4387155440"]},{"id":"https://openalex.org/I93396115","display_name":"The University of Notre Dame Australia","ror":"https://ror.org/02stey378","country_code":"AU","type":"education","lineage":["https://openalex.org/I93396115"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Gareth Baynam","raw_affiliation_strings":["Rare Care Centre, Perth Children's Hospital, Perth, Western Australia, Australia","University of Notre Dame, Medical Faculty, Sydney, New South Wales, Australia","University of Western Australia, Faculty of Health and Medical Sciences, Division of Paediatrics and Telethon Kids Institute, Perth, Western Australia, Australia"],"raw_orcid":"https://orcid.org/0000-0003-4920-9553","affiliations":[{"raw_affiliation_string":"Rare Care Centre, Perth Children's Hospital, Perth, Western Australia, Australia","institution_ids":["https://openalex.org/I2800419323","https://openalex.org/I4387155440"]},{"raw_affiliation_string":"University of Notre Dame, Medical Faculty, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I93396115"]},{"raw_affiliation_string":"University of Western Australia, Faculty of Health and Medical Sciences, Division of Paediatrics and Telethon Kids Institute, Perth, Western Australia, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027080373","display_name":"James O. J. Davies","orcid":"https://orcid.org/0000-0002-4108-4357","observed_orcids":["https://orcid.org/0000-0002-4108-4357"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210088942","display_name":"NIHR Oxford Biomedical Research Centre","ror":"https://ror.org/00aps1a34","country_code":"GB","type":"government","lineage":["https://openalex.org/I34931013","https://openalex.org/I4210088942","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I4387152343","display_name":"MRC Molecular Haematology Unit","ror":"https://ror.org/02khxwt12","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I4387152343","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Davies","raw_affiliation_strings":["MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK","NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, University of Oxford, Oxford, UK","NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-4108-4357","affiliations":[{"raw_affiliation_string":"MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210110594","https://openalex.org/I4387152343"]},{"raw_affiliation_string":"NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK","institution_ids":["https://openalex.org/I4210088942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114513873","display_name":"Shruti Mitkus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shruti Mitkus","raw_affiliation_strings":["Patient Services, Global Genes, Aliso Viejo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Services, Global Genes, Aliso Viejo, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010971466","display_name":"Oxana Iliach","orcid":"https://orcid.org/0000-0003-3979-7355","observed_orcids":["https://orcid.org/0000-0003-3979-7355"]},"institutions":[{"id":"https://openalex.org/I34752639","display_name":"Canadian Organization for Rare Disorders","ror":"https://ror.org/0033kcc14","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I34752639"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Oxana Iliach","raw_affiliation_strings":["Canadian Organization for Rare Disorders (CORD), Toronto, Ontario, Canada","Regulatory Strategy and Policy, Certara, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Canadian Organization for Rare Disorders (CORD), Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I34752639"]},{"raw_affiliation_string":"Regulatory Strategy and Policy, Certara, Toronto, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rich Horgan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rich Horgan","raw_affiliation_strings":["Cure Rare Disease, Woodbridge, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cure Rare Disease, Woodbridge, CT, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069764549","display_name":"Erika Fullwood Augustine","orcid":"https://orcid.org/0000-0001-7257-8985","observed_orcids":["https://orcid.org/0000-0001-7257-8985"]},"institutions":[{"id":"https://openalex.org/I1298154867","display_name":"Kennedy Krieger Institute","ror":"https://ror.org/05q6tgt32","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298154867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika F. Augustine","raw_affiliation_strings":["Clinical Trials Unit, Kennedy Krieger Institute, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Unit, Kennedy Krieger Institute, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1298154867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007655671","display_name":"Alison Bateman-House","orcid":"https://orcid.org/0000-0001-6921-9666","observed_orcids":["https://orcid.org/0000-0001-6921-9666"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison Bateman-House","raw_affiliation_strings":["Division of Medical Ethics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Ethics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032150304","display_name":"Anna M.G. Pasmooij","orcid":"https://orcid.org/0000-0003-0641-3829","observed_orcids":["https://orcid.org/0000-0003-0641-3829"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anna Maria Gerdina Pasmooij","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands","Science Department, Dutch Medicines Evaluation Board, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Science Department, Dutch Medicines Evaluation Board, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067147799","display_name":"Timothy W. Yu","orcid":"https://orcid.org/0000-0003-2988-7701","observed_orcids":["https://orcid.org/0000-0003-2988-7701"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim Yu","raw_affiliation_strings":["Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2988-7701","affiliations":[{"raw_affiliation_string":"Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031917279","display_name":"Matthis Synofzik","orcid":"https://orcid.org/0000-0002-2280-7273","observed_orcids":["https://orcid.org/0000-0002-2280-7273"]},"institutions":[{"id":"https://openalex.org/I2801533059","display_name":"German Center for Neurodegenerative Diseases","ror":"https://ror.org/043j0f473","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I2801533059","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210141865","display_name":"Hertie Institute for Clinical Brain Research","ror":"https://ror.org/04zzwzx41","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210141865","https://openalex.org/I8087733"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthis Synofzik","raw_affiliation_strings":["Division of Translational Genomics of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany","Research Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute of Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany"],"raw_orcid":"https://orcid.org/0000-0002-2280-7273","affiliations":[{"raw_affiliation_string":"Division of Translational Genomics of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I2801533059"]},{"raw_affiliation_string":"Research Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute of Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210141865","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073923411","display_name":"Julie Douville","orcid":"https://orcid.org/0000-0001-8783-6676","observed_orcids":["https://orcid.org/0000-0001-8783-6676"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Douville","raw_affiliation_strings":["ASO Discovery and Development, n-Lorem Foundation, Carlsbad, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASO Discovery and Development, n-Lorem Foundation, Carlsbad, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083284412","display_name":"Larissa Lapteva","orcid":"https://orcid.org/0000-0003-3205-8752","observed_orcids":["https://orcid.org/0000-0003-3205-8752"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larissa Lapteva","raw_affiliation_strings":["Division of Clinical Evaluation Pharmacology and Toxicology, Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Evaluation Pharmacology and Toxicology, Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002096733","display_name":"Philip John Brooks","orcid":"https://orcid.org/0000-0002-0567-6566","observed_orcids":["https://orcid.org/0000-0002-0567-6566"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148682","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210148682"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip John Brooks","raw_affiliation_strings":["National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210148682","https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040482265","display_name":"Daniel J O\u2019Connor","orcid":"https://orcid.org/0000-0001-7378-1125","observed_orcids":["https://orcid.org/0000-0001-7378-1125"]},"institutions":[{"id":"https://openalex.org/I2802722583","display_name":"Association of the British Pharmaceutical Industry","ror":"https://ror.org/02hgpw430","country_code":"GB","type":"other","lineage":["https://openalex.org/I2802722583"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel O\u2019Connor","raw_affiliation_strings":["Regulatory Policy & Early Access, The Association of the British Pharmaceutical Industry (ABPI), London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regulatory Policy & Early Access, The Association of the British Pharmaceutical Industry (ABPI), London, UK","institution_ids":["https://openalex.org/I2802722583"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033643112","display_name":"Annemieke M Aartsma-Rus","orcid":"https://orcid.org/0000-0003-1565-654X","observed_orcids":["https://orcid.org/0000-0003-1565-654X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Annemieke Aartsma-Rus","raw_affiliation_strings":["Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. A.M.Aartsma-Rus@lumc.nl","Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. A.M.Aartsma-Rus@lumc.nl","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":28,"corresponding_author_ids":["https://openalex.org/A5033643112"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":null,"apc_paid":null,"fwci":2.3555,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.91739569,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"24","issue":"1","first_page":"40","last_page":"56"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.26759999990463257,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.26759999990463257,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.17110000550746918,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11642","display_name":"Genomics and Rare Diseases","score":0.15610000491142273,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.8059999942779541},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.8339999914169312},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.7110000252723694},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.503000020980835},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.7210000157356262},{"id":"https://openalex.org/keywords/regulatory-challenges","display_name":"regulatory challenges","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ethical-issues","display_name":"ethical considerations","score":0.8519999980926514},{"id":"https://openalex.org/keywords/access-to-therapy","display_name":"access to therapy","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5079818367958069},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4564230144023895},{"id":"https://openalex.org/C48103436","wikidata":"https://www.wikidata.org/wiki/Q599031","display_name":"State (computer science)","level":2,"score":0.4288049042224884},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3347240686416626},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2024444043636322},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.19272252917289734},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000080907","descriptor_name":"Single-Case Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1038/s41573-024-01059-3","doi":"https://doi.org/10.1038/s41573-024-01059-3","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41573-024-01059-3","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},{"id":"pmid:39496921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39496921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Drug discovery","raw_type":"Journal Article"},{"id":"pmh:oai:ris.utwente.nl:openaire/2a674d39-c112-4535-b77c-1e5ce38a2363","doi":null,"is_oa":true,"landing_page_url":"https://research.utwente.nl/en/publications/2a674d39-c112-4535-b77c-1e5ce38a2363","pdf_url":null,"source":{"id":"https://openalex.org/S4406922991","display_name":"University of Twente Research Information","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2025, 'The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap', Nature Reviews Drug Discovery, vol. 24, e10486, pp. 40-56. https://doi.org/10.1038/s41573-024-01059-3","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:oai:pure.atira.dk:publications/40b0270d-3534-4d81-8599-61af798ca3b5","doi":null,"is_oa":false,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/40b0270d-3534-4d81-8599-61af798ca3b5","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Baynam, G 2025, 'The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap', Nature Reviews Drug Discovery, vol. 24, no. 1, e10486, pp. 40-56. https://doi.org/10.1038/s41573-024-01059-3","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:oai:dspace.library.uu.nl:1874/473945","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/473945","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:pub.dzne.de:274064","doi":null,"is_oa":false,"landing_page_url":"https://pub.dzne.de/record/274064","pdf_url":null,"source":{"id":"https://openalex.org/S7407051172","display_name":"DZNE Pub","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801533059","host_organization_name":"German Center for Neurodegenerative Diseases","host_organization_lineage":["https://openalex.org/I2801533059"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature reviews / Drug discovery 24(1), 40 - 56 (2025). doi:10.1038/s41573-024-01059-3","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:ris.utwente.nl:openaire/2a674d39-c112-4535-b77c-1e5ce38a2363","doi":null,"is_oa":true,"landing_page_url":"https://research.utwente.nl/en/publications/2a674d39-c112-4535-b77c-1e5ce38a2363","pdf_url":null,"source":{"id":"https://openalex.org/S4406922991","display_name":"University of Twente Research Information","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2025, 'The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap', Nature Reviews Drug Discovery, vol. 24, e10486, pp. 40-56. https://doi.org/10.1038/s41573-024-01059-3","raw_type":"info:eu-repo/semantics/review"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8999999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7699378943","display_name":"Functional genomics and development of clinical genome editing strategies","funder_award_id":"MC_UU_00029/4","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":108,"referenced_works":["https://openalex.org/W1544851750","https://openalex.org/W1990963334","https://openalex.org/W2023924430","https://openalex.org/W2078078890","https://openalex.org/W2086409978","https://openalex.org/W2132265655","https://openalex.org/W2140868856","https://openalex.org/W2411704989","https://openalex.org/W2588486271","https://openalex.org/W2606493012","https://openalex.org/W2609146840","https://openalex.org/W2728365508","https://openalex.org/W2738402542","https://openalex.org/W2743245152","https://openalex.org/W2744672018","https://openalex.org/W2771247031","https://openalex.org/W2775767511","https://openalex.org/W2795461643","https://openalex.org/W2805359783","https://openalex.org/W2903274455","https://openalex.org/W2904210127","https://openalex.org/W2909995413","https://openalex.org/W2928471857","https://openalex.org/W2939321522","https://openalex.org/W2942545249","https://openalex.org/W2943335541","https://openalex.org/W2946032909","https://openalex.org/W2947449763","https://openalex.org/W2971177113","https://openalex.org/W2973267506","https://openalex.org/W2979614510","https://openalex.org/W2982422932","https://openalex.org/W2988630324","https://openalex.org/W2994844251","https://openalex.org/W2998881619","https://openalex.org/W3011733694","https://openalex.org/W3014115276","https://openalex.org/W3017382633","https://openalex.org/W3023327298","https://openalex.org/W3045591471","https://openalex.org/W3047057879","https://openalex.org/W3091061098","https://openalex.org/W3092808100","https://openalex.org/W3112179900","https://openalex.org/W3128825549","https://openalex.org/W3139826906","https://openalex.org/W3150397896","https://openalex.org/W3164079530","https://openalex.org/W3164669759","https://openalex.org/W3177445623","https://openalex.org/W3203259389","https://openalex.org/W3207074037","https://openalex.org/W3210008249","https://openalex.org/W3214212058","https://openalex.org/W3214666165","https://openalex.org/W4206091342","https://openalex.org/W4206931214","https://openalex.org/W4210314012","https://openalex.org/W4210348552","https://openalex.org/W4210963185","https://openalex.org/W4214613209","https://openalex.org/W4220921384","https://openalex.org/W4245683663","https://openalex.org/W4281750571","https://openalex.org/W4283776907","https://openalex.org/W4283781395","https://openalex.org/W4285084439","https://openalex.org/W4292458118","https://openalex.org/W4292846877","https://openalex.org/W4293043553","https://openalex.org/W4293870383","https://openalex.org/W4296685812","https://openalex.org/W4307778264","https://openalex.org/W4308770459","https://openalex.org/W4311378564","https://openalex.org/W4313382384","https://openalex.org/W4317600180","https://openalex.org/W4318778265","https://openalex.org/W4320486562","https://openalex.org/W4322719307","https://openalex.org/W4323568260","https://openalex.org/W4365802645","https://openalex.org/W4367183963","https://openalex.org/W4376615273","https://openalex.org/W4380884537","https://openalex.org/W4384007545","https://openalex.org/W4384029797","https://openalex.org/W4384119978","https://openalex.org/W4385980779","https://openalex.org/W4387077861","https://openalex.org/W4388621454","https://openalex.org/W4388868301","https://openalex.org/W4388906867","https://openalex.org/W4389374562","https://openalex.org/W4389435297","https://openalex.org/W4389670532","https://openalex.org/W4390603683","https://openalex.org/W4391136234","https://openalex.org/W4391378976","https://openalex.org/W4391562488","https://openalex.org/W4392817264","https://openalex.org/W4393222223","https://openalex.org/W4399809748","https://openalex.org/W4400729394","https://openalex.org/W4403703996","https://openalex.org/W4404388316","https://openalex.org/W6848980275","https://openalex.org/W7073788162"],"related_works":["https://openalex.org/W4410777242","https://openalex.org/W7214377969","https://openalex.org/W4399906795","https://openalex.org/W4414498538","https://openalex.org/W3214666165","https://openalex.org/W7126191701","https://openalex.org/W7162013317","https://openalex.org/W4408025999","https://openalex.org/W4414712892","https://openalex.org/W4409813986"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":28},{"year":2025,"cited_by_count":17}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-11-05T00:00:00"}